Below, we discuss these aspects of altered BCAA metabolism in specific cancer types—pancreatic ductal adenocarcinomas (PDAC), hepatocellular carcinoma (HCC), breast cancer, non-small cell lung cancer (NSCLC), leukemia, glioblastoma, and other cell types in the tumor microenvironment. Here, ARID4B is linked to leukemia.